Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients.

scientific article published in September 2000

Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11020022

P2093author name stringGilli P
Catalano C
Di Landro D
Bordin V
Fabbian F
Cavagna R
Lambertini D
Squerzanti R
Tarroni G
P433issue3
P921main subjectAtrial FibrillationQ815819
P1104number of pages6
P304page(s)234-239
P577publication date2000-09-01
P1433published inClinical NephrologyQ15763520
P1476titleClinical characteristics associated to atrial fibrillation in chronic hemodialysis patients.
P478volume54

Reverse relations

cites work (P2860)
Q91588373Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis
Q37496206Atrial Fibrillation and Oral Anticoagulation in Chronic Kidney Disease
Q24798420Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality
Q37495851Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview
Q33940481Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).
Q37165278Cigarette smoking: an important renal risk factor - far beyond carcinogenesis
Q46661747Cigarette smoking: an important renal risk factor – far beyond carcinogenesis.
Q47097687Comparison of the CHADS2, CHA2DS2-VASc and R2CHADS2 Scores in Japanese Patients with Non-valvular Paroxysmal Atrial Fibrillation Not Receiving Anticoagulation Therapy
Q35040302Estimated glomerular filtration rate and proteinuria are separately and independently associated with the prevalence of atrial fibrillation in general population
Q35026672Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin.
Q44734027Increased P wave dispersion and maximum P wave duration after hemodialysis.
Q37205144Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan
Q37454324Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS
Q37469045Management of Atrial Fibrillation in Patients With Kidney Disease
Q36009279Prediction of Mortality in Incident Hemodialysis Patients: A Validation and Comparison of CHADS2, CHA2DS2, and CCI Scores
Q33684173Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease
Q61850990Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis
Q92447909Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
Q34534916The increasing prevalence of atrial fibrillation among hemodialysis patients
Q52901309The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis.
Q37477826The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients
Q34938763Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty

Search more.